PhenixFIN Corporation

NASDAQ:PFX

Asset Management

Financial Services
$39.40 -0.32%

-$0.14 today

Market cap
$76.09M
Beta
0.27
P/E (TTM)
-82.1
EPS (TTM)
-$0.53
Dividend yield
0.17%
52W Low $38.30High $53.59

Volume 0.00M

Average 0.00M

Financial health

PhenixFIN Corporation financial health

Start with the overall verdict and the rule-based risk checks for PFX, then work through liquidity, debt, balance-sheet quality, and claims on cash.

Financial health snapshot

Not Scored

Current ratio, interest coverage, and debt cushion are built for industrial companies and do not fit a financial company's balance sheet. Use the risk checks below alongside the company's regulatory capital ratios.

Cash & Investments

$3.37B

Total Debt

$149.13M

Shareholders' Equity

$153.81B

Debt / Equity

0.0x

Risk checks

0 of 3 flagged

Debt-service, liquidity, and payout checks are skipped for financial companies, whose borrowings and deposits are operating inputs.

  • Positive equity

    Positive

    Passes when: Shareholders' equity is above zero

  • Tangible equity base

    0.0%

    Passes when: Goodwill and intangibles are below 50% of equity

  • Limited dilution

    -5.8%/yr

    Passes when: Diluted share count grows less than 2% a year

Financial strength scores

How strong are the fundamentals over time?

Piotroski tests profitability, balance-sheet direction, and efficiency; Altman estimates bankruptcy risk. Compare the current scores with their fiscal-year history.

Financial strength scores

Piotroski F-Score and Altman Z-Score from the latest reported financials

Piotroski F-Score

Average

5 / 9

Nine pass/fail tests of profitability, balance-sheet strength, and efficiency. 8–9 is strong, 0–3 is weak.

Altman Z-Score

Not meaningful

-1.93

The Altman model was built for industrial companies; bank and real-estate balance sheets make it unreliable here.

Score history

Piotroski F-Score and Altman Z-Score recalculated from each fiscal year's statements and year-end market value.

Liquidity

Can it meet short-term obligations?

Check whether cash and current assets cover what falls due within a year without depending on fresh financing.

Cash & Equivalents

$3.07B

Q2 2026

3Y +650.6%1Y +90153.4%

Quick Ratio

91.0x

Q2 2026

Current Ratio

91.0x

Q2 2026

Cash Ratio

63.9x

Q2 2026

Working capital

How quickly does cash come back?

Receivable, inventory, and payable days show how much cash the operating cycle ties up and whether that is changing.

Working capital and cash conversion

Annual days measures from year-end receivables, inventory, and payables against revenue and cost of revenue.

Leverage

How much debt risk sits on the balance sheet?

Review total borrowings, debt relative to equity and assets, and whether operating profit covers interest costs.

Total Debt

$149.13M

Q2 2026

3Y +1.0%1Y +1.8%

Debt/Equity

0.0x

Q2 2026

Debt/Assets

0.0x

Q2 2026

Interest Coverage

1.6x

Q2 2026

Debt service

Can cash flow carry the debt?

Measure debt against EBITDA and free cash flow, see how much is due within 12 months, and follow debt and cash over time.

Debt service capacity

Can operating cash flow carry the debt, and how much is due soon?

Debt and cash over time

Fiscal-year-end borrowings against liquid assets; net debt below zero means net cash.

Balance sheet cushion

How much room is there if conditions weaken?

Extra cash and investments, and the balance of assets against liabilities, give the company room when trading gets harder.

Long-Term Investments

$295.81M

Q2 2026

Assets

$305.57B

Q2 2026

3Y +898.7%1Y +99312.3%

Liabilities

$151.76B

Q2 2026

3Y +903.6%1Y +100034.0%

Balance sheet quality

Who funds the assets, and how tangible is the equity?

Split the claims on assets between suppliers, lenders, customers, and shareholders, and see how much equity rests on goodwill and intangibles.

Balance sheet quality

Who funds the assets, and how much of the equity is tangible (Q2 2026).

Shareholder claims

What do shareholders take out of the cash?

Dilution, stock-based pay, dividends, and buybacks all draw on cash flow; check whether free cash flow funds them.

Shareholder claims on cash

Dilution, stock-based pay, and whether free cash flow funds what is returned to shareholders.

Diluted shares, yearly change

-5.8%

FY2020–FY2025 compound rate

Stock-based compensation

$0

Dividends paid

None

TTM to Q2 2026

Buybacks

$4.13M

TTM to Q2 2026

Weighted diluted shares outstanding

Competitor health

How does PhenixFIN Corporation compare with peers?

Compare leverage, interest coverage, and liquidity ratios with similar companies.

Competitor Health

Peer financial health comparison

CompanyMarket CapD/ED/AssetsND/EBITDAInt. Cov.QuickCurrentCash

Maase Inc.

MAAS:NASDAQ

$4.35B0.170.05Net cash—2.802.800.35

Great Elm Capital Corp. 8.50% Notes DUE 2029

GECCI:NASDAQ

$352.47M0.000.00Net cash1.490.000.000.00

Auburn National Bancorporation, Inc.

AUBN:NASDAQ

$88.41M0.000.00Net cash0.830.140.140.14

Hennessy Advisors, Inc.

HNNA:NASDAQ

$80.23M0.410.25Net cash5.7312.7212.7212.05

Bluemount Holdings Limited

BMHL:NASDAQ

$77.33M0.040.01Net cash21.771.031.500.06

Great Elm Capital Corp.

GECC:NASDAQ

$67.07M1.680.56Net cash—0.050.050.05

OFS Capital Corporation

OFS:NASDAQ

$49.37M1.770.63Net cash—0.740.740.74

Sol Strategies Inc.

STKE:NASDAQ

$43.04M0.450.31Net cash—0.110.110.05

Questions

Financial health questions

Common questions about PFX's balance sheet, answered from the reported figures.

Is PFX's balance sheet healthy?

PhenixFIN Corporation (PFX) has a current ratio of 90.96, a quick read on short-term liquidity.

How leveraged is PFX?

Debt to equity is 0.00, which helps judge how much financing risk sits on the balance sheet.